Notwithstanding different meningococcal serogroups have changed their distribution and
their impact in different age classes over time, N. meningitidis' invasive diseases are a major …

Objectives To understand the global landscape of prevention and control efforts targeting
serogroup B meningococcal (MenB) disease and to identify the key challenges and gaps yet …

Meningitis infection is one of the major threats during Hajj season in Mecca. Meningitis
vaccines are available, but their uses are limited in some countries due to religious reasons …

The efficacy of protein and carbohydrate antigens as vaccines can be improved via
particulate delivery strategies. Here, protein and carbohydrate antigens used in formulations …

ABSTRACT The European Medicines Agency has approved a multicomponent serogroup B
meningococcal vaccine (Bexsero®) for use in individuals of 2 months of age and older. A …

Invasive meningococcal disease (IMD) represents a severe risk for health. It can be
considered the most dangerous vaccine-preventable disease due to the high probability of …

In the last decades, tremendous advancement in dissecting the mechanisms of
pathogenicity of Neisseria meningitidis at a molecular level has been achieved, exploiting …

Invasive meningococcal disease (IMD), caused by Neisseria meningitidis, is life-threatening
with a high case fatality rate (CFR) and severe sequelae. We compiled and critically …

Neisseria meningitidis is a commensal of human nasopharynx and humans are the only
known reservoir and host of this bacterium. It is also known as a dangerous and devastating …

Near-infrared (NIR) spectroscopy is an attractive tool for pharmaceutical analyses. The main
purpose of this study was to assess the potential of NIR spectroscopy coupled with different …